These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38873997)

  • 1. Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer.
    Wu S; Zhao Q; Liu S; Kuang J; Zhang J; Onga A; Shen Y; Wang J; Sui H; Ni L; Ye Y; Tu X; Le HB; Zheng Y; Cui R; Zhu W
    Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38873997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells.
    Sui H; Xiao S; Jiang S; Wu S; Lin H; Cheng L; Ye L; Zhao Q; Yu Y; Tao L; Kong FM; Huang X; Cui R
    Neoplasia; 2023 May; 39():100897. PubMed ID: 36940556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
    Zhang Q; Chen M; Cao L; Ren Y; Guo X; Wu X; Xu K
    Mol Carcinog; 2020 Jun; 59(6):590-603. PubMed ID: 32189414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction.
    Xu Z; Shi Y; Zhu L; Luo J; Hu Q; Jiang S; Xiao M; Jiang X; Wang H; Xu Y; Jin W; Zhou Y; Wang P; Wang K
    Cancer Lett; 2024 Aug; 598():217075. PubMed ID: 38909775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A natural anthraquinone derivative shikonin synergizes with AZD9291 against wtEGFR NSCLC cells through reactive oxygen species-mediated endoplasmic reticulum stress.
    Hu X; Zhang ZY; Wu LW; Zeng LH; Chen H; Zhu HJ; Zhang JK; Shao J; Zhang C; Li YL; Lin NM
    Phytomedicine; 2020 Mar; 68():153189. PubMed ID: 32070867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis.
    Dai CH; Zhu LR; Wang Y; Tang XP; Du YJ; Chen YC; Li J
    J Cell Physiol; 2021 Jun; 236(6):4538-4554. PubMed ID: 33230821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hispidulin exhibits potent anticancer activity in vitro and in vivo through activating ER stress in non‑small‑cell lung cancer cells.
    Lv L; Zhang W; Li T; Jiang L; Lu X; Lin J
    Oncol Rep; 2020 Jun; 43(6):1995-2003. PubMed ID: 32236602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y; Song T; Shi Z; Li W; Yang S; Li D
    Gene; 2021 Feb; 768():145309. PubMed ID: 33197518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GOLPH3 inhibition overcomes cisplatin resistance by restoring the glutathione/reactive oxygen species balance in the A549 non‑small cell lung cancer cell line.
    Wei Q; Lin J; Lin Z; Yu N; Wu Y; Tan X; Xue D
    Oncol Rep; 2024 Dec; 52(6):. PubMed ID: 39422070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA‑PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC.
    Pan C; Duan H; Wu Y; Zhu C; Yi C; Duan Y; Lu D; Guo C; Wu D; Wang Y; Fu X; Xu J; Chen Y; Luo M; Tian W; Pan T; Xu W; Zhang S; Huang J
    Int J Oncol; 2020 Oct; 57(4):939-955. PubMed ID: 32945394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
    Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
    Shen Q; Xu Z; Xu S
    Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.
    Wang N; Song L; Xu Y; Zhang L; Wu Y; Guo J; Ji W; Li L; Zhao J; Zhang X; Zhan L
    EBioMedicine; 2019 Sep; 47():65-77. PubMed ID: 31495720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells.
    Zhou X; Sun T; Meng Y; Luo J; Chen J; Xia B; Zhang Z; Cheng Z; Wang X
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
    Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
    Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.
    Wang WJ; Mao LF; Lai HL; Wang YW; Jiang ZB; Li W; Huang JM; Xie YJ; Xu C; Liu P; Li YM; Leung ELH; Yao XJ
    Pharmacol Res; 2020 Nov; 161():105129. PubMed ID: 32783976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines.
    Hanke NT; Garland LL; Baker AF
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):549-60. PubMed ID: 26385374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression.
    Fan Z; Shuai H
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113172. PubMed ID: 39298823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.